WALTHAM, Mass., July 09, 2026 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE: CXT), a global leader in authentication and traceability technologies, today announced its schedule for the company's second quarter 2026 results.

globenewswire.com - 2026-07-09 16:05:00

STAMFORD, Conn.--(BUSINESS WIRE)--Crane Company (NYSE: CR) announces the following schedule and teleconference information for its second quarter 2026 earnings release: Earnings Release: July 28, 2026 after close of market by public distribution and the Crane Company website at www.craneco.com. Teleconference: July 29, 2026 at 10:00 AM (Eastern) hosted by Alex Alcala, President & CEO, and Richard A. Maue, Executive Vice President & CFO. The call can be accessed in a listen-only mode via.

businesswire.com - 2026-06-29 08:30:00

Vancouver, British Columbia – TheNewswire - June 29, 2026: Headwater Gold Inc. (CSE: HWG) (OTCQX: HWAUF) (the “Company” or “Headwater”) is pleased to announce that Centerra Gold Inc. (“Centerra”) (TSX: CG) has commenced drilling at Headwater's Crane Creek Project (“Crane Creek” or the “Project”) in western Idaho. The drill program is being operated and fully funded by Centerra pursuant to the earn-in agreement announced on December 3, 2025 . Highlights:

thenewswire.com - 2026-06-29 06:30:00

NEW YORK, June 18, 2026 /PRNewswire/ -- Brixmor Property Group Inc. (NYSE: BRX) ("Brixmor" or the "Company") announced today the release of its eighth annual Corporate Responsibility (CR) Report, which provides a comprehensive overview of the Company's CR strategy, initiatives, and 2025 performance. "This report highlights how central Corporate Responsibility is to how we operate and grow," stated Brian Finnegan, Chief Executive Officer and President.

prnewswire.com - 2026-06-18 07:55:00

enGene Therapeutics Inc. (Nasdaq: ENGN, “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines company today announced its financial

gurufocus.com - 2026-06-15 10:00:00

[url="]Genmab A/S[/url] (Nasdaq: GMAB) today announced new data from two studies evaluating epcoritamab, a T-cell engaging antibody administered subcutaneously

gurufocus.com - 2026-06-13 13:00:00

Investors need to pay close attention to CR stock based on the movements in the options market lately.

zacks.com - 2026-05-27 12:41:21

ImmunityBio, Inc. ([url="]NASDAQ: IBRX[/url]), a commercial-stage immunotherapy company, today announced an exclusive U.S. Development and Supply Agreement wit

gurufocus.com - 2026-05-16 14:00:00

On May 15, 2026, Crane Co (CR) shares fell 4.1% to a current price of $172.19. This decline comes in the context of a 52-week range that saw a high of $214.31 a

gurufocus.com - 2026-05-15 20:58:00

Crane NXT NYSE: CXT reported first-quarter 2026 sales growth and reaffirmed its earnings outlook while updating its full-year guidance to include the recently completed acquisition of Antares Vision.

marketbeat.com - 2026-05-09 21:06:48

Completes Acquisition of Antares Vision, a Global Leader in Inspection, Detection, and Track & Trace Technologies Delivers Organic Sales Growth of 6%; Maintains Full Year EPS Guidance of $4.10 to $4.40 WALTHAM, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE: CXT) ("Crane NXT" or the "Company"), a global leader in authentication and traceability technologies, today announced its financial results for the first quarter ended March 31, 2026.

globenewswire.com - 2026-05-06 16:05:00

On May 01, 2026, Crane Co (CR) shares fell 3.1% to $172.24. This decline comes amid a 52-week trading range of $159.58 to $214.31, indicating some volatility in

gurufocus.com - 2026-05-01 17:21:00

Crane Company (CR) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-04-28 15:21:43

STAMFORD, Conn.--(BUSINESS WIRE)--Crane Company ("Crane," NYSE:CR) today announced its financial results for the first quarter of 2026 and raised its full year adjusted EPS outlook. Alex Alcala, Crane's President and Chief Executive Officer, stated: "We delivered a very strong start to 2026, generating 15% adjusted EPS growth in the first quarter. Results exceeded our expectations with the majority of our outperformance driven by outstanding execution and momentum across our recent acquisitions.

businesswire.com - 2026-04-27 16:15:00

STAMFORD, Conn.--(BUSINESS WIRE)--Crane Company (NYSE: CR) today announced the completion of its previously disclosed CEO succession plan, effective April 27, 2026. Mr. Alex Alcala has assumed the role of President and Chief Executive Officer, succeeding Mr. Max Mitchell, who has transitioned to the role of Executive Chairman, as planned. Mr. Alcala brings thirteen years of experience within Crane and deep knowledge of the Company's markets, operations, and strategic priorities. During his tenu.

businesswire.com - 2026-04-27 08:30:00

Crane (NYSE: CR - Get Free Report) and EnWave (OTCMKTS:NWVCF - Get Free Report) are both industrials companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, profitability, earnings, institutional ownership and dividends. Analyst Ratings This is a summary of current ratings and

defenseworld.net - 2026-04-27 01:12:48

State of Alaska Department of Revenue lowered its stake in shares of Crane (NYSE: CR) by 54.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,892 shares of the conglomerate's stock after selling 5,869 shares during the quarter.

defenseworld.net - 2026-04-23 04:30:49

Crane Company remains rated a soft "Sell" due to high absolute valuation despite strong operational momentum and acquisition-driven growth. CR's 2026 guidance projects revenue of $2.845–$2.875 billion and adjusted EPS of $6.55–$6.75, with core sales expected to grow mid-single digits. Aerospace & Advanced Technologies outperforms with 14.7% revenue growth and backlog expansion, while Process Flow Technologies faces organic headwinds.

seekingalpha.com - 2026-04-20 18:28:26